Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
CLADRIBINE
JANSSEN INC
L01BB04
CLADRIBINE
1MG
SOLUTION
CLADRIBINE 1MG
INTRAVENOUS
10ML
Prescription
ANTINEOPLASTIC AGENTS
Active ingredient group (AIG) number: 0124270001; AHFS:
CANCELLED POST MARKET
2011-12-19
_C:\Windows\Temp\notesC47BC3\LEUSTATIN APM.doc _ _Page 1 of 34 _ PRODUCT MONOGRAPH PR LEUSTATIN ®* cladribine for Injection 1 mg/mL Antineoplastic/Chemotherapeutic Agent This Product Monograph is the exclusive property of Janssen Inc. It may not be copied in whole or in part without the written permission of Janssen Inc. Janssen Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 www.janssen.ca Date of Revision: November 2, 2010 SUBMISSION CONTROL NO: 139449 * All trademark rights used under license © 2010 JANSSEN Inc. _C:\Windows\Temp\notesC47BC3\LEUSTATIN APM.doc _ _Page 2 of 34 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION......................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................... 3 INDICATIONS AND CLINICAL USE..................................................................................... 3 CONTRAINDICATIONS .......................................................................................................... 4 WARNINGS AND PRECAUTIONS......................................................................................... 4 ADVERSE REACTIONS........................................................................................................... 8 DRUG INTERACTIONS ......................................................................................................... 12 DOSAGE AND ADMINISTRATION..................................................................................... 13 OVERDOSAGE ....................................................................................................................... 15 ACTION AND CLINICAL PHARMACOLOGY ................................................................... 15 STORAGE AND STABILITY................................................................................................. 17 SPECIAL HANDLING INSTRUCTIONS ............................................................................ 17 DOSAGE FORMS, COMPOSITION AND PACK Կարդացեք ամբողջական փաստաթուղթը